Pulse Biosciences (PLSE) Competitors $14.56 -2.87 (-16.47%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends PLSE vs. IRMD, SPNE, UTMD, ARAY, CTSO, AXNX, NVST, LIVN, NARI, and TMDXShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include Iradimed (IRMD), SeaSpine (SPNE), Utah Medical Products (UTMD), Accuray (ARAY), Cytosorbents (CTSO), Axonics (AXNX), Envista (NVST), LivaNova (LIVN), Inari Medical (NARI), and TransMedics Group (TMDX). These companies are all part of the "medical" sector. Pulse Biosciences vs. Iradimed SeaSpine Utah Medical Products Accuray Cytosorbents Axonics Envista LivaNova Inari Medical TransMedics Group Pulse Biosciences (NASDAQ:PLSE) and Iradimed (NASDAQ:IRMD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, community ranking, institutional ownership, risk, profitability, media sentiment, valuation, analyst recommendations and earnings. Do institutionals & insiders have more ownership in PLSE or IRMD? 76.9% of Pulse Biosciences shares are owned by institutional investors. Comparatively, 92.3% of Iradimed shares are owned by institutional investors. 71.5% of Pulse Biosciences shares are owned by company insiders. Comparatively, 37.1% of Iradimed shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community favor PLSE or IRMD? Iradimed received 5 more outperform votes than Pulse Biosciences when rated by MarketBeat users. Likewise, 64.78% of users gave Iradimed an outperform vote while only 64.49% of users gave Pulse Biosciences an outperform vote. CompanyUnderperformOutperformPulse BiosciencesOutperform Votes24764.49% Underperform Votes13635.51% IradimedOutperform Votes25264.78% Underperform Votes13735.22% Which has more volatility and risk, PLSE or IRMD? Pulse Biosciences has a beta of 1.74, indicating that its share price is 74% more volatile than the S&P 500. Comparatively, Iradimed has a beta of 0.79, indicating that its share price is 21% less volatile than the S&P 500. Which has better earnings and valuation, PLSE or IRMD? Iradimed has higher revenue and earnings than Pulse Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,274.83-$42.21MN/AN/AIradimed$69.48M8.81$17.19M$1.4633.08 Does the media prefer PLSE or IRMD? In the previous week, Pulse Biosciences and Pulse Biosciences both had 12 articles in the media. Iradimed's average media sentiment score of 0.54 beat Pulse Biosciences' score of 0.48 indicating that Iradimed is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Iradimed 1 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Is PLSE or IRMD more profitable? Iradimed has a net margin of 26.83% compared to Pulse Biosciences' net margin of 0.00%. Iradimed's return on equity of 24.71% beat Pulse Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -126.10% -91.24% Iradimed 26.83%24.71%20.86% Do analysts recommend PLSE or IRMD? Iradimed has a consensus price target of $60.00, indicating a potential upside of 24.22%. Given Iradimed's higher probable upside, analysts plainly believe Iradimed is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AIradimed 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryIradimed beats Pulse Biosciences on 11 of the 14 factors compared between the two stocks. Ad Crypto 101 MediaMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…All you have to do is claim your free ticket to the event now… Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$892.38M$4.45B$5.33B$8.52BDividend YieldN/A41.87%5.07%4.13%P/E RatioN/A42.95125.0415.83Price / Sales1,274.8361.401,492.5992.35Price / CashN/A49.3439.5134.18Price / Book17.984.264.765.07Net Income-$42.21M$11.52M$118.77M$225.38M7 Day Performance-17.37%1.16%-0.38%0.06%1 Month Performance-12.02%1.98%6.06%3.93%1 Year Performance232.42%33.87%38.12%32.51% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences1.4135 of 5 stars$14.56-16.5%N/A+232.4%$892.38M$700,000.000.00140Earnings ReportNews CoverageIRMDIradimed4.8625 of 5 stars$49.27-6.9%$60.00+21.8%+17.6%$670.74M$65.56M33.75110Dividend AnnouncementNews CoverageHigh Trading VolumeSPNESeaSpineN/A$9.54flatN/A+0.0%$354.92M$191.45M-5.39523Analyst ForecastGap DownUTMDUtah Medical Products3.9597 of 5 stars$63.38-1.0%N/A-19.1%$222.60M$50.22M14.84180Analyst UpgradeNews CoverageARAYAccuray4.2196 of 5 stars$1.73-8.0%$9.00+420.2%-31.9%$188.51M$446.55M-10.81987Upcoming EarningsCTSOCytosorbents1.9252 of 5 stars$1.01flat$2.00+98.0%-32.0%$54.97M$36.35M-1.91186Upcoming EarningsAnalyst ForecastNews CoverageAXNXAxonics3.795 of 5 stars$70.30+0.0%$71.00+1.0%+35.9%$3.59B$366.38M-1,757.06610Upcoming EarningsShort Interest ↓Positive NewsNVSTEnvista4.3091 of 5 stars$20.97+9.0%$20.63-1.6%-8.9%$3.31B$2.57B-2.7012,800Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageHigh Trading VolumeLIVNLivaNova4.4844 of 5 stars$51.62+0.5%$69.17+34.0%+2.2%$2.79B$1.15B122.902,900Analyst ForecastNews CoverageNARIInari Medical3.1996 of 5 stars$48.40+2.8%$58.89+21.7%-20.6%$2.76B$493.63M-35.851,300Analyst ForecastInsider SellingAnalyst RevisionTMDXTransMedics Group4.2544 of 5 stars$81.97+0.1%$144.80+76.6%+116.6%$2.75B$241.62M87.20210Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage Related Companies and Tools Related Companies IRMD Competitors SPNE Competitors UTMD Competitors ARAY Competitors CTSO Competitors AXNX Competitors NVST Competitors LIVN Competitors NARI Competitors TMDX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PLSE) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | Sponsored[Just Released] Jovine's Emergency Briefing insidePeople didn't believe Jovine when he predicted the 2008 financial crisis over a year in advance. But some read...Behind the Markets | SponsoredHe made 1,303,329 in 12 months after Biden won…Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… ...Timothy Sykes | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
